Sep. 28, 2005 – Acacia Research Corp. announced its CombiMatrix Group (Nasdaq:CBMX) has received a one year $338,000 contract from the U.S. Air Force for the development and production of microarrays to detect pathogens that cause upper respiratory infections and pathogens that infect wounds.
The contract is the result of a collaborative effort with the Air Force Institute of Occupational Health that led to the development of a rapid assay and microarray that identifies all forms of influenza A, including bird flu.